📰 Limflow Inc News

Limflow Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Limflow Inc. Real-time updates on events, politics, business and more.

Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented

November 1, 2023

Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings.

New Zealand United States Mahmood Razavi Gore Viabahn Anvar Babaev Thomas Zeller

Source: dicardiology.com

First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

October 31, 2023

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

United States New Zealand Thomas Zeller Daniel Clair Anvar Babaev Osamu Iida

Source: prnewswire.com

LimFlow System's 6-Month Outcomes Presented From the PROMISE II US Pivotal Trial

November 4, 2022

November 4, 2022&mdash;Six-month results from the PROMISE II United States pivotal trial of transcatheter arterialization of the deep veins with the L

United States Daniel Clair Las Vegas Foundation On Limflow Inc Late Breaking Clinical Trials

Source: evtoday.com

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA22

November 2, 2022

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Thomas Maldonado Petera Soukas Wynn Las Vegas Michael Lichtenberg Ido Weinberg Daniel Clair

Source: prnewswire.com